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Final report of the project, Dissemination of Knowledge of Emergency Contraception among 
Service Providers and Factory Personnel, conducted in Mexico during January-March 1999. This 
study was funded by the U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID) 
under the terms of Cooperative Agreement number HRN-A-00-98-00012-00, Subproject number 
5801.13003.421. The opinions expressed herein are those of the author and do not necessarily reflect 
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The goal of this project was to inform physicians, pharmacists, and female factory workers about 
emergency contraception through mailings of booklets and posters. These materials had been developed 
in a previous operations research project conducted by the Instituto Mexicano de Investigación de 
Familia y Población (IMIFAP) and supported by the Population Council INOPAL III project. Both 
activities were funded by the U.S. Agency for International Development. 
 
This dissemination project consisted of distributing the following print materials: 
 
§ A four-page booklet to inform physicians about emergency contraception (EC), which was inserted 
into a magazine sent to 15,000 physicians as well as mailed to a separate list of 3,065 private 
physicians; 
§ A four-page booklet to give pharmacists basic information about EC, which was inserted into a 
magazine sent to 15,500 pharmacies as well as mailed to a separate list of 1,075 pharmacies; and 
§ A booklet and poster mailed to 2,107 assembly plants located near the U.S./Mexico border. 
 
The impact of the mailings was assessed by analyzing responses to three questionnaires mailed to the 
three major audiences. Questionnaire respondents generally liked the print materials and welcomed 
information about EC. Within three weeks of receiving the materials, many respondents reported that 
they had taken immediate action to make EC available and/or to educate others about EC: 
 
§ Nearly all physicians said that they had already given information to women in need of EC; 
§ Most physicians had discussed EC with their colleagues; 
§ Some physicians had given a talk about EC to their medical colleagues or had consulted them about 
implementing EC services; 
§ Most pharmacists had already provided information about EC to women and had discussed EC 
with other staff members; 
§ Nearly all of the respondents from assembly plants said that they had discussed the materials with 
other staff members; and 
§ One in five of the physicians and respondents from assembly plants stated that they had 
disseminated information about EC through the mass media. 
 
Most respondents wanted more information about EC. Only a few respondents were opposed to EC. 
 




contraception at a relatively low cost. The booklets reached more than 18,000 physicians and 16,500 
pharmacists. The booklets and posters sent to 2,107 assembly plants reached an estimated audience of 
1.1 million reproductive-age women. The project cost $27,978, of which the major components were 
printing and postage. 
 
This experience indicates that reproductive health organizations can be effective in making information 
about EC and related services widely available. Public and private agencies in Mexico and other 
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A. Evaluation Questionnaires 
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Emergency contraception (EC) is a method that women can use to prevent pregnancy following 
unprotected sexual intercourse (sex without contraception or a contraceptive accident). Emergency 
contraception uses contraceptives that are widely available and accepted in most countries. The two 
contraceptive methods most commonly used for emergency contraception are: 
 
Until recently, most family planning and reproductive health programs in Mexico have not offered 
counseling on emergency contraceptive methods. Some program directors may be concerned about 
public criticism because of the misconception that EC is an abortifacient. As a result, most service 
providers and reproductive-age women in Mexico do not know about EC. 
 
In Latin America, the Population Council and other partners recently conducted three emergency 
contraception projects that tested: 
 
1. The acceptability of EC as an element in the care of rape victims, conducted by the Attorney 
General’s Office in Mexico City (Vernon, Schiavon and Llaguno, 1997). 
2. The acceptability of EC as a contraceptive method in outpatient clinics, programs for adolescents, 
and centers that care for rape victims, conducted by four organizations in Ecuador with technical 
assistance from the International Center for Research on Women (Paolisso et al., 1998). 
§ Combined oral contraceptives. Women who have unprotected intercourse may avoid an 
unwanted pregnancy by taking oral contraceptives as soon as possible and within 72 hours after 
intercourse. The usual dose is two contraceptive pills with 50 mcg ethynil estradiol/150 mcg 
levonorgestrel, followed by two additional pills after 12 hours. In the case of low-dose pills (30 mcg 
ethynil estradiol/250 mcg levonorgestrel), four pills must be taken in the first 72 hours after 
unprotected intercourse, followed by four additional pills after 12 hours. There are no known 
contraindications for these regimes. Studies have found that 98 percent of the women who take 
them as instructed do not become pregnant. Side effects include nausea (in approximately 50% of 
the cases), irregular uterine bleeding and breast tenderness. 
 
§ Intra-uterine devices (IUDs). Copper-medicated IUDs may also be used as an emergency 
contraceptive. They should be inserted within the first five days following unprotected intercourse. 
Studies have found the effectiveness of this treatment to be as high as 99 percent in preventing 
pregnancy. The contraindications for IUD use as emergency contraception are the same as those for 
regular IUD use (IPPF, 1994). 
 
 
Mexico: Information about Emergency Contraception   2 
 
3. Strategies to disseminate information on EC through various mass and interpersonal media, 
conducted by the Instituto Mexicano de Investigación de Familia y Población (IMIFAP) in Mexico 
City, funded by the Population Council INOPAL III project (Givaudan et al., 1998). 
 
See Vernon (1998) for information on other EC programs in Latin America conducted by the 
Population Council and other organizations. 
 
These projects have shown that emergency contraception is well-accepted by providers and clients who 
need the method for a variety of reasons (such as rape, condom breakage, and unforeseen sexual 
relations). The IMIFAP study in Mexico (Givaudan et al. 1998) demonstrated that targeted 
communication interventions did raise knowledge about EC. The proportion of private physicians who 
knew about EC increased from 38 percent in the baseline survey to 61 percent in the endline survey, 
while knowledge among pharmacists rose from 5 percent to 26 percent. After posters were displayed 
on the campus of the National University of Mexico, the proportion of students who reported knowing 





The objective of this project was to expand the use of the results of the IMIFAP project to inform 
service providers and female factory workers in U.S./Mexico border towns about emergency 
contraception through mailings of booklets and posters. This project was designed to address 




III. INTERVENTIONS AND RESULTS 
 
Mailing of Booklets to Physicians and Pharmacists 
 
The booklets that IMIFAP had printed and distributed in the INOPAL III project were reviewed by 
three reproductive health experts (Rafaella Schiavon, Consultant; Emma Ottolenghi, Population Council; 
and Jeffey Spieler, USAID). The revised versions – 40,000 copies of the four-page booklet for 
physicians and 87,500 copies of the four-page booklet for pharmacists – were printed by 
FRONTIERS. 
 
To identify potential recipients of the mailings, PC/FRONTIERS staff searched for lists of physicians 
and pharmacies. The process was slow and difficult. Pharmaceutical companies and commercial editors 
would not agree to give or sell their lists. Through personal contacts, staff found a solution. A business 
editor who edits two courtesy magazines for physicians and pharmacists agreed to insert booklets within 
the magazines. Two copies of the EC booklet for physicians were included inside one issue of the 
magazine DIVERSION, which is mailed to 15,000 physicians. Five copies of the booklet for 
pharmacists were included inside one issue of Pasatiempo Farmaceutico, which is mailed to 15,500 
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pharmacies. Thus, a total of 30,000 booklets for physicians and 77,500 booklets for pharmacists were 
distributed as magazine inserts. 
 
In addition, one booklet was mailed to 3,065 private physicians whose names and addresses were 
collected through other sources (such as the National Federation of Obstetricians/Gynecologists) and to 
1,075 pharmacies that are members of the National Chamber of Commerce (CANACO). A few 




Mailing of Booklets and Posters to Assembly Plants in Mexico 
 
FRONTIERS staff contacted various institutions and professional associations to obtain a list of 
assembly plants in Mexico. A directory compiled by the National Chamber of the Transformation 
Industry (CANACINTRA) was found. Since an electronic version of the directory was not available, 
addresses for 2,107 assembly plants were keyed in to produce a mailing list. Five copies each of the 
booklet for physicians, the booklet for rape victims, and the poster were mailed to each of the assembly 
plants. Eighty-one envelopes were returned due to address changes and other reasons. Since the 2,107 
assembly plants have an average of 534 employees each, more than 1.1 million people, mostly women 





 To evaluate the impact of the mailings, PC/FRONTIERS staff sent three questionnaires to physicians, 
pharmacists and assembly plants on the mailing/distribution lists (see Appendix A for the three 
questionnaires). By the project’s end on April 30, 1999 (just three weeks after the mailings), 
PC/FRONTIERS had received 40 responses from physicians, 14 responses from pharmacists, and 75 





All 40 physicians who responded to the questionnaire had a private office. In addition, 23 physicians 
worked at public health facilities and 27 at private health facilities. All of them had read the booklet. 
Nearly all respondents (37 out of 40) rated it “very good” or “good.” The booklet led to other 
important dissemination behaviors: 
 
 






Of the 14 pharmacists who had contacted PC/FRONTIERS by the project’s end, 12 answered the 
questionnaire, one requested more materials, and one confirmed receipt of the booklets. All of the 
questionnaire respondents had read the booklet. Nine respondents considered the booklet “very good,” 
and three rated it “good.” Major behavioral outcomes were: 
 
Assembly Plant Workers 
 
Of the 2,107 assembly plants, 79 company representatives contacted PC/FRONTIERS before the 
project end; 60 people filled out questionnaires and 19 requested further information. All respondents 
had read the materials. Eight in 10 respondents said they had displayed the posters in their plants. About 
one half of the respondents considered the booklet “very good” and the rest (with one exception) 
considered it “good.” Half (51%) of the respondents said that the poster was “very good,” and 36 
percent considered it “good.” 
 
§ All but one of the physicians said that they had already given information to women in need of EC. 
§ 60 percent reported that they had given a talk on EC to colleagues in their clinic or hospital, and 35 
percent had given a talk for colleagues in another clinic or hospital. 
§ 87 percent had discussed the booklet with other colleagues. 
§ 35 percent had trained other health staff members in EC service delivery. 
§ Nearly one in four physicians said that they had consulted their colleagues about implementing EC 
services at their work sites. 
§ 22 percent had disseminated information on EC through the mass media (only one specified a 
popular radio program). 
§ 40 percent had searched for more information about EC. 
 
Of the physicians who added comments, several mentioned the acceptability of EC and the lack of 
information about it. Some physicians requested further information. 
§ Ten pharmacists said that they had given information about EC to women who needed it. 
§ Eleven pharmacists had shared the booklet and discussed it with other staff members 
§ Six pharmacists had asked questions or sought more information on EC. 
 
The most frequent comments from pharmacists were congratulations on the initiative, reports of sharing 
the information with staff members, family and friends, and agreement with the use of EC, especially in 
cases of rape. Only one respondent reported any difficulties; he had received a complaint from a 
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Following are some of the behavioral outcomes: 
 
This project showed that targeted mailings to key audiences can increase awareness of emergency 
contraception at a relatively low cost. The materials had sufficient information to enable recipients to 
take immediate action and to discuss EC authoritatively. The booklets reached more than 18,000 
physicians and 16,500 pharmacists. The booklets and posters sent to 2,107 assembly plants reached an 
estimated audience of 1.1 million reproductive-age women. The project cost $27,978, of which the 
major components were printing and postage. 
 
Initial reactions from physicians, pharmacists and representatives of assembly plants were 
overwhelmingly positive. Respondents expressed strong interest in knowing more about EC and had 
already discussed EC with their colleagues, clients, customers, and peers. 
 
This experience indicates that reproductive health organizations can be effective in making information 
about EC and related services widely available. Public and private agencies in Mexico and other 
Spanish-speaking countries should replicate or modify the existing materials and distribute them widely. 
§ Ninety-five percent of the plant representatives said that they had discussed the materials with other 
staff members. 
§ 80 percent had shared the materials with others. 
§ 21 percent said they had disseminated information on EC through the media. 
§ 15 percent said they had searched for more information on EC. 
 
In addition, three respondents reported that they had given talks on EC to all of their employees. 
 
Nearly 40 percent of the plant representatives requested additional information and materials. One 
person asked for samples of the pills. Three respondents remarked that the information was very useful 
at their plants, since the great majority of employees were women of fertile age. Many respondents 
congratulated the project for sending the information. 
 
Three respondents reported that the materials had caused problems, but they did not specify the nature 
of these problems. Two respondents stated that they did not agree with the method. 
 
 
V.  CONCLUSIONS AND RECOMMENDATIONS 
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CUESTIONARIO EVALUACIÓN ANTICONCEPCIÓN DE EMERGENCIA 
(Médicos) 
1. ¿En cuáles de los siguientes tipos de establecimientos presta sus servicios? 
                         (circule todos los que correspondan) 
 
Atención en clínica, centro de salud u hospital del sector salud .....1 
 
Atención en clínica u hospital privado     ...........................2 
        
Consultorio privado  .............................................. ..3 
 
Otro ____________________________ ....................................4 
(especifique) 
 
2. ¿Leyó usted el folleto adjunto? 
 
SI        NO 
 
¿Cómo lo calificaría? 
 




3.  Desde que recibió el folleto informativo ¿ha llevado a cabo alguna de las siguientes 









Dar una plática informativa para otros colegas/otro personal de mi 

























Capacitar a otros médicos, consejeros u otro personal para que 








Difundir por algún medio de comunicación el tema de la anticoncepción 








Proporcionar información verbal sobre anticoncepción de emergencia a 








Investigar a sobre el tema en la bibliografía anexa o en otras 







Llevar a cabo reuniones con otros colegas/otro personal para discutir 
la conveniencia o posibilidad de implantar actividades de 
anticoncepción de emergencia en el consultorios/clínicas/hospitales. 








3. En caso de que haya llevado alguna de estas actividades, ¿ha tenido algunos problemas, o han 
sido bien recibidas las actividades? 
 
He tenido problemas ............................ 1     





Por favor comente al respecto: 
 




CUESTIONARIO EVALUACIÓN ANTICONCEPCIÓN DE EMERGENCIA 
(Farmacias) 
 
1. ¿Leyó usted el folleto? 
 
SI         NO 
 
¿Cómo lo calificaría? 
 
Muy bueno   1 
Bueno    2 
Regular   3 
 
  
2. Desde que recibió el folleto informativo ¿ha llevado a cabo alguna de las 









Comentar con otro personal de la farmacia sobre la 
información del folleto 
 1 2 
Compartir con otro personal de la farmacia la información 
del folleto  
 1  2 
Proporcionar información verbal sobre anticoncepción de 
emergencia a mujeres que lo requieran. 
 1  2 
Preguntar/investigar sobre el tema   1  2 
 
 
2. En caso de que haya llevado alguna de estas actividades, ¿ha tenido algunos 
problemas, o han sido bien recibidas las actividades? 
 
He tenido problemas ............................ 1 
Han sido bien recibidas ........................ 2 
 
 




















CUESTIONARIO EVALUACION ANTICONCEPCION DE EMERGENCIA 
(Maquiladoras) 
 
1 Desde que recibió los materiales ¿ha llevado a cabo alguna de las siguientes 























Comentar con otro personal de su empresa sobre la 














Difundir por algún medio de comunicación el tema de la 






Preguntar/investigar a sobre el tema en otras fuentes 






2. Por favor, califique los materiales que haya leído. 
 
Folleto 
Muy bueno ......................... 1 




Muy bueno ......................... 1 
Bueno ..............................  2 
Regular.............................. 3 
 
3.  En caso de que haya exhibido o repartido los materiales ¿ha tenido algunos 
problemas, o fueron bien recibidos?  
 
He tenido problemas ............................ 1 
Han sido bien recibidos ........................ 2 
 







       




Muchas gracias por su colaboración. 
